Inventor · disambiguated record
Shingo Tojo
Also filed as: TOJO SHINGO
6 granted patents·10 pending applications·9 citations·filing 2006–2022
74Inventor score
Files withBOSTON BIOMEDICAL INC4SUMITOMO DAINIPPON PHARMA CO LTD4DAINIPPON SUMITOMO PHARMA CO3SUMITOMO PHARMA CO LTD3ABBOT PHILIP1
Top patents by PatentIndex Score
16 records- 0183US9828362B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Nov 28, 2017·5 cites·14 claims
- 0277US10703755B2Substituted purine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Jul 7, 2020·2 cites·27 claims
- 0372US9227962B2Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2014·Granted Jan 5, 2016·1 cites·18 claims
- 0470US10807945B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Oct 20, 2020·1 cites·27 claims
- 0569US11661397B21,4-disubstituted imidazole derivativeSUMITOMO PHARMA CO LTD·Filed 2020·Granted May 30, 2023·0 cites·7 claims
- 0659US2019241550A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 0758US2025084098A1Fused-ring amine derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0851US2016075697A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 0950US2023365589A1Novel amine derivativesSUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1048US2016031888A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 1148US2023138851A1Novel alkyne derivativesCARNA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1247US2019241569A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1344US2008269240A1Novel Adenine CompoundDAINIPPON SUMITOMO PHARMA CO·Filed 2006·Application pending·0 cites
- 1441US2009082332A1Purine derivatives for the treatment of viral or allergic diseases and cancersABBOT PHILIP·Filed 2006·Application pending·0 cites
- 1536US2011136801A1Novel CompoundsDAINIPPON SUMITOMO PHARMA CO·Filed 2010·Application pending·0 cites
- 1633US10898469B2Imidazolylamide derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Jan 26, 2021·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Shingo Tojo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →